3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
17
Breast Neoplasms
15
Leukemia
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Leukemia, Myeloid, Chronic-Phase
10
Recurrence
8
Prostatic Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Lung Neoplasms
7
Neoplasm Metastasis
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Melanoma
5
Burkitt Lymphoma
5
Pancreatic Neoplasms
4
Leukemia, Myeloid, Acute
4
Glioblastoma
4
Blast Crisis
4
Squamous Cell Carcinoma of Head and Neck
3
Ovarian Neoplasms
3
Neoplasms
3
Lymphoma
3
Gliosarcoma
3
Sarcoma
2
Salivary Gland Neoplasms
2
Rhabdomyosarcoma
2
Rectal Neoplasms
2
Polycythemia Vera
2
Oligodendroglioma
2
Multiple Myeloma
2
Lymphoma, Large B-Cell, Diffuse
2
Interventions
Imatinib Mesylate
6
Cytarabine
5
ponatinib
4
nilotinib
4
venetoclax
3
fludarabine phosphate
3
Mycophenolic Acid
3
thymoglobulin
2
fludarabine
2
enasidenib
2
Methotrexate
2
Lenalidomide
2
Cyclosporine
2
Cyclophosphamide
2
Azacitidine
2
Antilymphocyte Serum
2
quizartinib
1
methanesulfonic acid
1
glasdegib
1
etoposide phosphate
1
daratumumab
1
bosutinib
1
asciminib
1
Whole-Body Irradiation
1
Transplantation
1
Temozolomide
1
Tacrolimus
1
Stem Cell Transplantation
1
Standard of Care
1
RFT5-SMPT-dgA immunotoxin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Myeloid
×
Dasatinib
×
Clear all
No trials found.